ARB Topical A5F

ARB Topical A5F

Brand: ADEGEN
SKU: A5F-90
79.00 USD In stock Buy at Merchant

ARB Topical A5F is Adegen's foundational prescription-strength topical with finasteride added for DHT defense. It combines 5% minoxidil and topical finasteride with our proprietary ARB complex, plus tretinoin, caffeine, and a niacinamide + biotin blend to support absorption and overall follicle health. Compounded in-house at Adegen Pharmacy and formulated to help key ingredients reach the follicle, where healthy hair growth begins, A5F addresses both growth support and DHT defense in one formula, a strong fit for pattern thinning driven by DHT. About the Finasteride in This Formula Finasteride inhibits the primary enzyme (Type II) responsible for converting testosterone to DHT in the scalp, helping reduce the hormone that drives pattern hair loss. Prefer our strongest DHT defense? Dutasteride, which inhibits both Type I and Type II enzymes, is available in A5D. Full Formulation ARB Proprietary Complex (designed to support the androgen receptor and follicle environment) Micronized Minoxidil 5% (50 mg/mL) Finasteride 0.3% (3 mg/mL) Caffeine 0.2% (2 mg/mL) Niacinamide + Biotin Blend 0.3% (3 mg/mL) Tretinoin 0.01% (0.1 mg/mL) Delivered via proprietary DermalDrive™ topical delivery system Best For Early to moderate thinning, and anyone who wants growth support and added DHT defense in a single formula. Safety & Rx Information This is a prescription-only compounded medication dispensed through Adegen Pharmacy, our licensed 503A compounding pharmacy. A licensed physician will review your information after checkout and determine if this formula is appropriate for you. Women who are pregnant or may become pregnant should not handle this product.

Specifications
Supply Duration
90-Day Supply, 30-Day Supply
Variants (2)
  • 90-Day Supply — 199.00 USD — In stock
  • 30-Day Supply — 79.00 USD — In stock

How AI sees this product

The more complete this product's details, the more confidently AI assistants can understand and recommend it.

87%